DaVita Inc. (NYSE: DVA) is one of the largest dialysis providers in the United States. Their U.S. dialysis and related lab services business treats patients with chronic kidney failure, ESKD, in the United States, and is their largest line of business. DaVita’s platform to deliver kidney care services also includes established nephrology and payor relationships. The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare). As of December 31, 2023, the Company operated or provided administrative services through a network of 2,675 U.S. outpatient dialysis centers in 46 states and the District of Columbia, serving a total of approximately 200,800 patients. In addition, the company operated or provided administrative services to a total of 367 outpatient dialysis centers serving approximately 49,400 patients located in 11 countries outside of the U.S. The company’s 2023 market cap was $9.56B, and its 2023 reported revenue was $11.6B. DaVita is now headquartered in Denver, Colorado.

DaVita Inc. (NYSE: DVA) is one of the largest dialysis providers in the United States. Their U.S. dialysis and related lab services business treats patients with chronic kidney failure, ESKD, in the United States, and is their largest line of business. DaVita’s platform to deliver kidney care services also includes established nephrology and payor relationships. The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare). As of December 31, 2023, the Company operated or provided administrative services through a network of 2,675 U.S. outpatient dialysis centers in 46 states and the District of Columbia, serving a total of approximately 200,800 patients. In addition, the company operated or provided administrative services to a total of 367 outpatient dialysis centers serving approximately 49,400 patients located in 11 countries outside of the U.S. The company’s 2023 market cap was $9.56B, and its 2023 reported revenue was $11.6B. DaVita is now headquartered in Denver, Colorado.

DaVita Inc. (NYSE: DVA) is one of the largest dialysis providers in the United States. Their U.S. dialysis and related lab services business treats patients with chronic kidney failure, ESKD, in the United States, and is their largest line of business. DaVita’s platform to deliver kidney care services also includes established nephrology and payor relationships. The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare). As of December 31, 2023, the Company operated or provided administrative services through a network of 2,675 U.S. outpatient dialysis centers in 46 states and the District of Columbia, serving a total of approximately 200,800 patients. In addition, the company operated or provided administrative services to a total of 367 outpatient dialysis centers serving approximately 49,400 patients located in 11 countries outside of the U.S. The company’s 2023 market cap was $9.56B, and its 2023 reported revenue was $11.6B. DaVita is now headquartered in Denver, Colorado.

DaVita Inc. (NYSE: DVA) is one of the largest dialysis providers in the United States. Their U.S. dialysis and related lab services business treats patients with chronic kidney failure, ESKD, in the United States, and is their largest line of business. DaVita’s platform to deliver kidney care services also includes established nephrology and payor relationships. The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare). As of December 31, 2023, the Company operated or provided administrative services through a network of 2,675 U.S. outpatient dialysis centers in 46 states and the District of Columbia, serving a total of approximately 200,800 patients. In addition, the company operated or provided administrative services to a total of 367 outpatient dialysis centers serving approximately 49,400 patients located in 11 countries outside of the U.S. The company’s 2023 market cap was $9.56B, and its 2023 reported revenue was $11.6B. DaVita is now headquartered in Denver, Colorado.

DaVita Inc. (NYSE: DVA) is one of the largest dialysis providers in the United States. Their U.S. dialysis and related lab services business treats patients with chronic kidney failure, ESKD, in the United States, and is their largest line of business. DaVita’s platform to deliver kidney care services also includes established nephrology and payor relationships. The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare). As of December 31, 2023, the Company operated or provided administrative services through a network of 2,675 U.S. outpatient dialysis centers in 46 states and the District of Columbia, serving a total of approximately 200,800 patients. In addition, the company operated or provided administrative services to a total of 367 outpatient dialysis centers serving approximately 49,400 patients located in 11 countries outside of the U.S. The company’s 2023 market cap was $9.56B, and its 2023 reported revenue was $11.6B. DaVita is now headquartered in Denver, Colorado.

DaVita Inc. (NYSE: DVA) is one of the largest dialysis providers in the United States. Their U.S.
dialysis and related lab services business treats patients with chronic kidney failure, ESKD, in
the United States, and is their largest line of business. DaVita’s platform to deliver kidney care
services also includes established nephrology and payor relationships. The company was
founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises,
Inc. (now Tenet Healthcare). As of December 31, 2023, the Company operated or provided
administrative services through a network of 2,675 U.S. outpatient dialysis centers in 46 states
and the District of Columbia, serving a total of approximately 200,800 patients. In addition, the
company operated or provided administrative services to a total of 367 outpatient dialysis
centers serving approximately 49,400 patients located in 11 countries outside of the U.S. The
company’s 2023 market cap was $9.56B, and its 2023 reported revenue was $11.6B. DaVita is
now headquartered in Denver, Colorado.

DaVita Inc. (NYSE: DVA) is one of the largest dialysis providers in the United States. Their U.S. dialysis and related lab services business treats patients with chronic kidney failure, ESKD, in the United States, and is their largest line of business. DaVita’s platform to deliver kidney care services also includes established nephrology and payor relationships. The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare). Today, DaVita has a network of 2,724 outpatient dialysis centers in 46 states and the District of Columbia, serving a total of approximately 199,400 patients. Additionally, their international operations provided dialysis and administrative services to a total of 350 outpatient dialysis centers located in 11 countries outside of the U.S., serving approximately 45,600 patients. The company’s market cap is about $8.82B, and their 2022 reported revenue was $11.6B. DaVita is now headquartered in Denver, Colorado.

DaVita Inc. (NYSE: DVA) is one of the largest dialysis providers in the United States. Their U.S. dialysis and related lab services business treats patients with chronic kidney failure, ESKD, in the United States, and is their largest line of business. DaVita’s platform to deliver kidney care services also includes established nephrology and payor relationships. The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare). Today, DaVita has a network of 2,724 outpatient dialysis centers in 46 states and the District of Columbia, serving a total of approximately 199,400 patients. Additionally, their international operations provided dialysis and administrative services to a total of 350 outpatient dialysis centers located in 11 countries outside of the U.S., serving approximately 45,600 patients. The company’s market cap is about $8.82B, and their 2022 reported revenue was $11.6B. DaVita is now headquartered in Denver, Colorado.

DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers. The Company has more than 2,816 outpatient dialysis centers in the United States, serving 204,200+ patients, and 321 outpatient dialysis centers in 10 other countries serving 3,200+ patients. The U.S. dialysis business treats patients with chronic kidney failure, and end-stage kidney disease (ESKD). The company has a 37% market share in the U.S. dialysis market. In 2020, 70% of the company's revenues came from Medicare and other government health insurance programs. DaVita also operates 154 outpatient dialysis centers in 12 countries outside the U.S. The company’s market cap is about $9.6B. In 2021 revenue was $11.6B. The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. DaVita is now headquartered in Denver, Colorado.